Annals of Pharmacotherapy (AOP)

The Annals of Pharmacotherapy is a peer-reviewed medical journal published monthly by SAGE Publications in the United States. It serves as an important platform for clinicians, researchers, pharmacists, and healthcare professionals interested in advancing the science and practice of pharmacotherapy. Since its inception in 1967, the journal has evolved through several title changes to become a leading forum for high-quality research and evidence-based reviews on medication use, drug safety, and therapeutic strategies. Topics commonly covered include medication effectiveness in clinical settings, drug interactions and adverse events, pharmacoeconomics, pharmacokinetics and pharmacogenomics, pharmacoepidemiology, clinical informatics, and outcomes research. The journal also publishes insightful commentaries, editorials on professional issues, and comprehensive reviews of new therapeutic agents and controversies in drug therapy. Its content aims to enhance patient care by disseminating cutting-edge evidence that informs clinical decision-making, optimizes treatment protocols, and promotes rational use of pharmaceuticals across diverse patient populations. The Annals of Pharmacotherapy is indexed in major scientific databases and recognized for its rigorous peer-review process and broad international readership within medicine and pharmacy fields.

Annals of Pharmacotherapy (AOP) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacology (medical), focuses on drug therapy, medication effectiveness, safety, pharmacokinetics, pharmacoeconomics, pharmacoepidemiology, clinical use of medicines to improve patient outcomes. , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1060-0280, E-ISSN: 1542-6270, Established: 1967, Impact Factor: 2.3
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE